The positive correlation between CDK12 and c-myc expression emphasizes its function in triggering the c-myc/β-catenin signaling pathway, which may be a mechanism promoting the renewal of breast cancer stem cells [187]. This evidence concerns the gene CDK12 and breast carcinoma.